American Portfolios Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $491K | Sell |
4,619
-96
| -2% | -$10.2K | 0.02% | 651 |
|
|
2022
Q2 | $460K | Sell |
4,715
-182
| -4% | -$17.7K | 0.02% | 699 |
|
|
2022
Q1 | $459K | Buy |
4,897
+2,822
| +136% | +$265K | 0.02% | 768 |
|
|
2021
Q4 | $177K | Buy |
2,075
+148
| +8% | +$12.6K | 0.01% | 1219 |
|
|
2021
Q3 | $185K | Buy |
1,927
+8
| +0.4% | +$767 | 0.01% | 1148 |
|
|
2021
Q2 | $187K | Sell |
1,919
-404
| -17% | -$39.3K | 0.01% | 1135 |
|
|
2021
Q1 | $226K | Buy |
2,323
+30
| +1% | +$2.92K | 0.01% | 969 |
|
|
2020
Q4 | $220K | Buy |
2,293
+38
| +2% | +$3.64K | 0.01% | 854 |
|
|
2020
Q3 | $217K | Buy |
2,255
+1,765
| +360% | +$170K | 0.01% | 764 |
|
|
2020
Q2 | $59.8K | Sell |
490
-18
| -4% | -$2.2K | ﹤0.01% | 1224 |
|
|
2020
Q1 | $44K | Sell |
508
-271
| -35% | -$23.5K | ﹤0.01% | 1214 |
|
|
2019
Q4 | $83.7K | Buy |
779
+83
| +12% | +$8.92K | 0.01% | 1142 |
|
|
2019
Q3 | $62.7K | Sell |
696
-43
| -6% | -$3.88K | 0.01% | 1186 |
|
|
2019
Q2 | $62.4K | Buy |
739
+389
| +111% | +$32.8K | 0.01% | 1172 |
|
|
2019
Q1 | $30.8K | Hold |
350
| – | – | ﹤0.01% | 1399 |
|
|
2018
Q4 | $25K | Hold |
350
| – | – | ﹤0.01% | 1291 |
|
|
2018
Q3 | $43K | Buy |
+350
| New | +$43K | ﹤0.01% | 1179 |
|